
This conference will examine next steps for improving patient access to innovative medicines and maximising benefits from health technologies in the UK.
With the Government’s Life Sciences Sector Plan and 10 Year Health Plan setting out priorities for research, innovation and NHS reform, attendees will consider key issues for regulation, appraisal, health technology assessment, adoption across the NHS and commercial arrangements for new treatments.

